Atossa Therapeutics, Inc. (ATOS)
NASDAQ: ATOS · Real-Time Price · USD
1.880
+0.110 (6.21%)
At close: Jun 26, 2026, 4:00 PM EDT
1.887
+0.007 (0.37%)
After-hours: Jun 26, 2026, 7:50 PM EDT
Atossa Therapeutics Stock Forecast
ATOS's stock price has decreased by -85.46% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Atossa Therapeutics stock have an average target of 18, with a low estimate of 10 and a high estimate of 24. The average target predicts an increase of 857.45% from the current stock price of 1.88.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Atossa Therapeutics stock from 2 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 2 | 2 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 3 | 3 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Buy Maintains $20 | Buy | Maintains | $20 | +963.83% | Jun 3, 2026 |
| Ascendiant | Ascendiant | Buy Maintains $24 | Buy | Maintains | $24 | +1,176.60% | Apr 9, 2026 |
| Craig-Hallum | Craig-Hallum | Buy Maintains $35 → $10 | Buy | Maintains | $35 → $10 | +431.91% | Feb 12, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-4.40
from -4.04
EPS Next Year
-4.38
from -4.40
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | n/a | n/a | |
| Avg | n/a | n/a | |
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2027 | 2028 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -4.40 | -4.38 | |
| Avg | -4.40 | -4.38 | |
| Low | -4.40 | -4.38 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.